TazanolastAlternative Names: MTB; Tazalest; Tazanol; WP 833
Latest Information Update: 24 Nov 1998
At a glance
- Originator Torii Pharmaceutical; Wakamoto
- Class Antiallergics; Antiasthmatics; Tetrazoles
- Mechanism of Action Mast cell stabilisers
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Marketed Asthma